The RLT Safety Playbook: Advancing Safety Assessment and Long-Term Risk Management for Therapeutic Radiopharmaceutical Development

• Examining key clinical safety challenges in therapeutic radiopharmaceutical development
• Discussing approaches to longitudinal safety monitoring and characterisation throughout the development lifecycle
• Exploring how emerging clinical experience can inform benefit risk assessment and safety strategies for next-generation radioligand therapies

Speakers:

Ilya Folitar

Senior Global Program Safety Team Lead and Radiopharmaceutical Safety Lead

Novartis